Physician profile
Adria Young
NPI 1649709015
$2,355.14
in general payments reported to CMS, 2019-2025
17 companies · $452 in 2025
The $452 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $639 · 2020: $133 · 2021: $242 · 2022: $311 · 2023: $383 · 2024: $196 · 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,030.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,029.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $604.79 | 2020-2025 | Total30, Clareon Panoptix Pro, Clareon |
| Johnson & Johnson Surgical Vision, INC. | $371.22 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $310.54 | 2019-2023 | |
| Bausch & Lomb Americas INC. | $128.95 | 2022-2023 | Miebo, Xiidra |
| Horizon Therapeutics Plc | $125.00 | 2023 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $121.69 | 2025 | Xdemvy |
| Optovue, INC. | $117.61 | 2019 | |
| Sight Sciences, INC. | $116.10 | 2021-2022 | |
| Shire North American Group INC | $95.85 | 2019 | |
| Biotissue Holdings INC. | $95.20 | 2022-2024 | |
| Coopervision INC. | $78.73 | 2023 | Myday Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $51.22 | 2020-2021 | |
| Rxsight INC | $44.33 | 2022 | |
| Aerie Pharmaceuticals, INC. | $37.55 | 2019-2021 | |
| Dompe US, INC. | $22.67 | 2025 | Oxervate |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $17.41 | 2021 | |
| Abbvie INC. | $16.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adria Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.